The cDNA encoding the N-terminal 41% of human apolipoprotein B (apoB), apoB-41, was transfected into nonhepatic, nonintestinal, mammary-derived mouse cells (C127) to generate stably transfected cells expressing human apoB-41 (C127B-41). As determined by centrifugation, apoB-41 is secreted exclusively on lipoproteins (LPs) having a peak density of 1.13 g/ml. Electron microscopy of apoB-41-containing LPs purified by immunoaffinity chromatography showed round particles about 12 nm in diameter. No discoidal particles were observed. Characterization of apoB-41-associated lipids after labeling C127B-41 cells with
[3H]oleate and immunoprecipitating the secreted LPs with antibodies to apoB showed that 3H-labeled triacylglycerols were a major lipid class and accounted for about 54% of the total labeled lipids. Cholesterol esters and phospholipids accounted for about 6% and 22%, respectively. Incubation of cells with 0.4 mM oleate resulted in an increased incorporation of the added oleate into lipids associated with secreted apoB-41, along with a 2-to 3-fold increased secretion of apoB-41. The newly formed LPs appear to be transported through the Golgi complex, as brefeldin A (1 lig/ml) and monensin (1 ,uM) greatly reduced (>90%) the secretion of labeled apoB-41 and the amount of triacylglycerol and phospholipid associated with it. Microsomal triacylglycerol transfer protein (MTP) was not detected in these cells. Taken together, the data presented demonstrate that apoB-41 can direct the assembly and secretion of LPs that contain a triacylglycerol-rich core in nonhepatic cells that apparently lack MTP. These cells, therefore, represent an important model for studying LP assembly and may offer some advantages over cultured hepatic or intestinal cells that express their endogenous apoB gene.
Apolipoprotein B (apoB) is a large hydrophobic glycoprotein (1) (2) (3) (4) synthesized in the liver and the intestine that is essential for the assembly and secretion of triacylglycerol (TAG)-rich lipoproteins (LPs) (5, 6) . Two forms of apoB are found in plasma, apoB-100 and apoB-48. ApoB-100 is a 4536 amino acid protein synthesized in the liver and secreted on very low density lipoproteins (VLDL) (1) (2) (3) (4) . It is the major protein constituent of low density lipoprotein (LDL) and is the ligand for the receptor-mediated clearance of LDL (7) . ApoB-48 is a truncated form corresponding to the N-terminal 48% of apoB-100, generated by a posttranscriptional modification of apoB-100 mRNA that results in a stop codon at Gln-2153 (8, 9) . ApoB-48 is synthesized mainly in the intestine and is secreted on chylomicrons (10) .
ApoB-48 contains the structural elements required to direct the formation of chylomicrons and VLDL (8) . Peptides as short as the N-terminal 37% of apoB also appear sufficient to direct VLDL formation (11) . Information derived from cultured hepatoma cells expressing truncated forms of apoB suggests that the length of apoB is directly correlated with the size and inversely correlated with the density of the secreted LPs (12) (13) (14) (15) (16) (17) .
Early steps in the synthesis of apoB, as with the synthesis of most secretory proteins (18) , involve the cotranslational translocation of the nascent peptide across the endoplasmic reticulum (ER) membrane into the ER lumen. However, the appearance of apoB in the ER lumen occurs more slowly than is typical for other secreted proteins, as it is preceded by additional steps. These include cotranslational binding of apoB to the ER membrane (19) (20) (21) , where segments of apoB are exposed on the cytosolic surface of the ER (22) (23) (24) (25) , and cotranslational association of apoB with lipids (15) to form small LPs of high density lipoprotein (HDL) and LDL densities (19) . The complete translocation of apoB into the ER lumen is followed by a rapid transport to the Golgi complex (21) . Some have suggested that VLDL-sized particles are formed in the ER (19, 26, 27) and, more specifically, at the junction between the rough and smooth ER (26) , while others have suggested that lipids are added to apoB-containing LPs in the Golgi complex (20, 28) .
The regulation of apoB secretion appears to be post-or cotranslational (29) , as factors affecting the secretion levels of apoB do not significantly affect steady state mRNA levels or the synthesis of apoB (14, 30, 31) . Degradation of newly synthesized apoB is a major regulatory mechanism, as only a fraction of the newly synthesized apoB (5-41%) gets translocated through the ER membrane, becomes associated with lipids, and is secreted (22, (32) (33) (34) . The nonsecreted portion remains membrane-bound and is targeted for degradation (23) by proteolytic enzymes residing in a pre-Golgi compartment (22, 34) . Lipid availability partly determines the efficiency of secretion, as oleate appears to increase apoB secretion by reducing its degradation (14, 32) .
The assembly of apoB with lipids appears to be mediated by microsomal triacylglycerol transfer protein (MTP). Wetterau and colleagues showed that the absence of the large subunit of MTP that is associated with mutations in its gene is linked to the inability to secrete apoB-containing LPs in patients with abetalipoproteinemia (35, 36) . Additional factor(s) may be involved in LP assembly, since patients with chylomicron retention disease express normal apoB and MTP (35) but are unable to secrete chylomicrons (6) . Thus, while we have a general knowledge about LP assembly and secretion, the factors and the details of the path from translocation of apoB to secretion of TAG-rich LPs are incompletely defined.
Cultured liver cells have been widely used in secretion studies; however, these cells normally synthesize and secrete a variety of apolipoproteins, including apoB. To determine if LP assembly is mediated by factors that are unique to liver or intestinal cells, we have used a mouse mammary tumor-derived cell line (C127) that does not synthesize apoB or secrete LPs to generate cell lines that express C-terminally truncated forms of human apoB (37, 38) . The line expressing the N-terminal 41% of apoB (apoB-41) assembles apoB-41 into LP particles that contain a TAG-rich core.
MATERIALS AND METHODS
Cell Cultures. Permanently transfected C127 cells expressing a human apoB-41 cDNA (Fig. 1) were grown as described (37, 39) . In all experiments, cells were incubated in serum-free (SF) medium (37, 39 EDTA/0.02% NaN3 containing leupeptin and aprotinin, each at a final concentration of 10 ,ug/ml. Medium was used directly for immunoprecipitation or was first subjected to either density-gradient (40) or sequential ultracentrifugation (41) . Cells were washed in cold phosphate-buffered saline (PBS; 10 mM sodium phosphate/120 mM NaCl/2.7 mM KCl), pH 7.4 and then lysed in 1% Triton X-100 in PBS containing protease inhibitors as above. Cellular protein was determined according to Markwell et al. (42) or Lowry et al. (43) by using a kit from Bio-Rad. Immunoprecipitation and Immunoblotting. Cell lysates or culture medium samples were precleared with protein GSepharose, incubated overnight at 4°C with goat antiserum to human apoB (BioDesign), and then incubated for 45 min with protein G-Sepharose. The protein G-Sepharose beads that were incubated with culture medium were washed with PBS. The beads that were incubated with cell lysates were first washed with PBS/1% Triton X-100, then with PBS/0.5% SDS/0.5% Triton X-100 and then with PBS alone. Lipids were isolated from culture medium by two extractions of the samples with 1 ml of chloroform/methanol (2:1, vol/vol). The protein was extracted by boiling the Sepharose beads in sample buffer (44) for 3-5 min and then resolved by SDS/7% PAGE (44) and autoradiography.
Immunoblotting was performed as described (37) .
Analysis of Lipids Associated with ApoB-41. Culture medium conditioned by C127B-41 cells in the presence of
[3H]oleate for 24 h was collected, adjusted to p = 1.25 g/ml with solid KBr, and ultracentrifuged in an SW55Ti rotor (Beckman) at 50,000 rpm for 40 h at 8°C. The p < 1.25 g/ml fractions were immunoprecipitated, and the lipids were separated by TLC and quantified by liquid scintillation spectrometry (37, 39) . To identify the mass of lipids associated with apoB-41, culture medium was subjected to immunoaffinity chromatography as described below, followed by ultracentrifugation at p = 1.25 g/ml. The lipids in the p < 1.25 g/ml fractions were separated by TLC and identified by charring with 50% H2SO4.
Immunoaffinity Chromatography. Conditioned medium was incubated successively with gelatin-Sepharose (to remove fibronectin), protein G-Sepharose, and with an immunoadsorbent constructed by cross-linking apoB antibodies to protein G-Sepharose modified as by Schneider et al. (45) . After extensive washing, apoB-containing LPs were eluted from the beads with 0.1 M glycine, pH 2.5. Fractions were neutralized, adjusted to 1 mM EDTA/0.02% NaN3, and centrifuged at p = 1.25 g/ml as described above. The top (p < 1.25 g/ml) and bottom (p > 1.25 g/ml) fractions were collected and analyzed.
Negative Stain EM. Aliquots from the p < 1.25 g/ml fraction obtained after immunoaffinity chromatography were negatively stained (37) (Fig. 2B) . Analysis of apoB-41-associated 3H-labeled lipids showed that labeled TAG, cholesterol ester (CE), and phospholipid accounted for about 54, 6 , and 22%, respectively, of total labeled lipids ( Table 1) . Inclusion of 0.4 mM oleate resulted in about a 20-fold increase in the relative intracellular composition of oleate-labeled TAG and CE (data not shown), and increased incorporation of added [3H]oleate into lipid associated with apoB-41 ( Table 1) . Despite increased incorporation of added oleate, there was no distribution of lipids into the LDL density range (data not shown). The presence or absence of oleate did not affect the relative composition of 3H-labeled lipid associated with apoB-41 ( Table 1) . Taken together, the data show that apoB-41 must be assembled with lipids, especially TAG and phospholipid, to be secreted.
Composition analysis of the lipids associated with apoB-41 (obtained by immunoaffinity chromatography followed by centrifugation at p = 1.25 g/ml) by TLC and charring with H2SO4 confirmed the presence of TAG as a major lipid (data not shown).
Oleate (0.4 mM) increased the secretion of apoB-41 2-to 3-fold as measured by laser densitometry of blots of the p < 1.25 g/ml fractions of conditioned medium. Similar results were obtained by measuring the secretion of 35S-labeled apoB-41 after incubation with oleate (data not shown). Thus, the amount of apoB-41 that could be assembled with lipids prior to its secretion by C127 cells is closely correlated with lipid availability.
Negative stain EM showed that apoB-41-containing LPs were roughly round particles, usually ranging from 8 to 25 nm Therefore, the original lipid is probably monoalkyl DAG. in diameter. In some fields rare particles with a diameter of 35-50 nm were seen (Fig. 3) . The size distribution showed that particles isolated from cells incubated with oleate were slightly larger (12.6 ± 2.8 nm) than those isolated from cells incubated without added oleate (10.9 ± 3.1 nm) (mean ± SD, 250 particles measured). This size difference is not statistically significant. There were no discoidal particles observed in any field. Therefore, consistent with the high content of core lipids, we conclude that apoB-41 is secreted on emulsion-like LPs.
Brefeldin A (BFA) and monensin are drugs that perturb the transport of newly synthesized proteins from the ER to the Golgi complex (46, 47) Table I Origin --legend.
reducing its synthesis (Fig. 4A) . Similarly, secretion of 3H-labeled TAG was almost abolished (>90%) and secretion of phosphatidylcholine was greatly reduced in the presence of BFA (Fig. 4B) , without their synthesis being affected (data not shown). Despite the lack of TAG and phosphatidylcholine in medium obtained from cells treated with BFA, there were some other lipids (mainly fatty acids) immunoprecipitated from the medium (Fig. 4B) . These lipids could have bound nonspecifically to protein GSepharose or to some components in the antiserum. These lipids were not found when medium was subjected to ultracentrifugation prior to immunoprecipitation. The effect of BFA and monensin on the secretion of apoB-41 was studied in a pulse-chase experiment. Fig. 5 shows that BFA and monensin reduced secretion of apoB-41 by 86 and 70%, respectively. The results of both experiments suggest that apoB-41 is transported from the ER to the Golgi complex prior to its secretion. It is important to note that after a 2-h chase, only about 20% of the radioactivity present at the beginning of the chase was recovered. Thus, the major fraction, about 80% of the newly synthesized apoB-41, is degraded. (Fig. 24) , like apoB-41-, apoB-42-, or apoB-48-containing LPs secreted by cultured hepatoma cells (13, 14) . (22, 34) . Under these conditions it appears that the number of apoB-41-containing particles increases, but the size and composition of the particles do not change significantly. The mean diameter of apoB-41-containing LPs is in the range of 11-13 nm (Fig. 3) , consistent with the expected size of LPs containing apoB-42 secreted by hepatic cells (12) . Thus 
